Sort
25,944 grants matching “neurodegeneration”
Modeling Frontotemporal Dementia in Rhesus Macaques
$488,011Marina Emborg · University Of Wisconsin-Madison · R61 · FY2019 · NS
Elucidating mechanisms of SIRT1 activation
$487,967David A. Sinclair · Harvard Medical School · R01 · FY2020 · DK
Decoding protein MARylation networks in astrocytes using chemical biology approaches
$487,946Michael S Cohen · Oregon Health & Science University · R01 · FY2024 · NS
The Role of Drosha in the Pathogenesis of Alzheimer's Disease
$487,892Zixu Mao · Emory University · R01 · FY2016 · NS
Mechanisms of Catecholaminergic Neurodegeneration
$487,871David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Mediterranean Diet, Biological Aging, and Risk for Disease and Disability Progression in Multiple Sclerosis
$487,772Ilana Beth Katz Sand · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS
A Novel Method to Enhance Drug Delivery to the Brain
$487,741Teruna J. Siahaan · University Of Kansas Lawrence · R01 · FY2024 · AG
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
$487,663Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · NS
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
$487,663Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · NS
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
$487,663Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · NS
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
$487,663Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · NS
Novel Cognitive Markers of Early Alzheimer's Disease.
$487,621Diane M. Jacobs · University Of California, San Diego · R01 · FY2020 · AG
Network modulation to improve gene therapy in CLN3 disease
$487,607Rebecca Clare Ahrens-Nicklas · Children'S Hosp Of Philadelphia · R01 · FY2024 · NS
Network modulation to improve gene therapy in CLN3 disease
$487,607Rebecca Clare Ahrens-Nicklas · Children'S Hosp Of Philadelphia · R01 · FY2023 · NS
Network modulation to improve gene therapy in CLN3 disease
$487,607Rebecca Clare Ahrens-Nicklas · Children'S Hosp Of Philadelphia · R01 · FY2025 · NS
The Role of Appoptosin in Alzheimer's Disease and Other Tauopathies
$487,500Huaxi Xu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · AG
The Role of Appoptosin in Alzheimer's Disease and Other Tauopathies
$487,500Huaxi Xu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AG
The Role of Appoptosin in Alzheimer's Disease and Other Tauopathies
$487,500Huaxi Xu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · AG
The Role of Appoptosin in Alzheimer's Disease and Other Tauopathies
$487,500Huaxi Xu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · AG
BEHAVIORAL CHARACTERIZATION OF ACUTE&CHRONIC AMPHETAMINE
$487,423University Of California San Diego · R01 · FY2004 · DA
Hormesis/Adaptive Stress Responses and Aging
$487,384Mark Mattson · National Institute On Aging · ZIA · FY2018 · AG
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit
$487,337Karsten Gronert · University Of California Berkeley · R01 · FY2024 · EY
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit
$487,337Karsten Gronert · University Of California Berkeley · R01 · FY2023 · EY
Ectodermal-neural cortex 1 and neuronal vulnerability to tau pathology in Alzheimer's disease
$487,154Hongjun Fu · Ohio State University · R01 · FY2022 · AG
Proteasome dysfunction as a driver of age-associated risk for Alzheimer's disease onset and progression
$487,127Andrew Michael Pickering · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG